Avantor (AVTR) announced an expanded partnership with the National Institute for Bioprocessing Research and Training. The new collaboration will focus on addressing urgent bottlenecks in biopharma manufacturing, particularly in downstream optimization for monoclonal antibodies (mAbs), by providing cutting-edge equipment and specialized training. Avantor will provide a full suite of leading aseptic fluid handling equipment, including Masterflex pump systems and supporting single-use systems. These advanced tools are designed to create realistic biopharmaceutical workflows in NIBRT’s state-of-the-art training rooms, offering trainees the opportunity to gain hands-on experience with equipment that mirrors real-world industry settings.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR:
- AVTR Earnings this Week: How Will it Perform?
- Avantor put volume heavy and directionally bearish
- Avantor closes divestiture of clinical services business to Audax Private Equity
- Avantor call volume above normal and directionally bullish
- Avantor announces virtual power purchase agreement through Energize program